This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Non-seminoma of testis
C3_TESTIS_NONSEMINOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
225 |
4. Check minimum number of eventsNone |
225 |
5. Include endpointsNone |
225 |
6. Filter based on genotype QC (FinnGen only) |
225 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Non-seminoma of testis
based on the number of shared cases.
Similar with more cases:
- Non-seminoma of testis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 225 | - | 225 |
| Unadjusted period prevalence (%) | 0.10 | - | 0.10 |
| Median age at first event (years) | 30.78 | - | 30.78 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 203
- Matched controls
- 2029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
194.3
154
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
582.0
183.1
158
12
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
291.1
134.8
125
11
130
Kela drug reimbursment
Malignant tumour
40.9
77.6
99
46
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
57.0
52
*
JN4BD
NOMESCO Finland
Extensive body CT
20.9
53.7
84
66
A03FA01
ATC
metoclopramide; systemic, rectal
16.1
53.1
95
105
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
50.1
46
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
45.5
48.5
59
18
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
45.5
42
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
536.4
45.1
43
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
18.9
39.2
62
46
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
37.7
35
*
L03AA02
ATC
filgrastim; parenteral
36.3
32.2
41
14
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
32.1
30
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
101.6
31.8
34
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
31.0
29
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.3
27.3
118
418
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
25.5
24
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
56.0
25.0
29
6
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
270.5
24.2
24
*
A04AA02
ATC
granisetron; systemic, transdermal
20.9
23.6
35
20
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
23.4
22
*
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
46.0
23.3
28
7
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
90.3
22.2
24
*
JN4AD
NOMESCO Finland
Body CT examination
11.9
21.3
40
41
H02AB02
ATC
dexamethasone; systemic
11.8
20.8
39
40
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.9
20.5
55
103
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
64.4
20.4
23
*
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
20.1
19
*
DFF00
NOMESCO Finland
Pure tone audiometry
9.5
18.1
38
48
A04AA01
ATC
ondansetron; systemic, rectal
13.3
17.7
31
27
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
16.9
16
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
13.9
16.4
28
23
121
Kela drug reimbursment
Severe hypofunction of sexual glands
21.4
16.0
23
12
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
+∞
14.8
14
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
161.0
14.7
15
*
JN3AD
NOMESCO Finland
Abdominal CT examination
8.0
14.4
33
48
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
43.2
13.4
16
*
N02BE01
ATC
paracetamol; systemic, rectal
3.8
13.3
171
1184
D70.82
ICD-10 Finland
Drug-induced neutropenia
53.6
13.0
15
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
53.6
13.0
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
12.3
73
291
B01AB05
ATC
enoxaparin; parenteral
3.9
12.1
56
182
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.0
12.0
25
31
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
11.6
11
*
18699
ICD-8 Finland
Malignant neoplasm of testis
126.8
11.5
12
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
16.7
11.0
17
11
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.0
10.8
21
23
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
115.7
10.5
11
*
C62
ICD-10 Finland
Malignant neoplasm of testis
115.7
10.5
11
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
10.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
24.9
10.4
14
6
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.0
10.3
34
79
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
10.3
81
382
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
10.2
40
111
WW500
NOMESCO Finland
Blood transfusion
17.9
10.0
15
9
B01AB10
ATC
tinzaparin; parenteral
9.1
9.8
20
24
N05BA06
ATC
lorazepam; systemic, sublingual
9.4
9.5
19
22
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
23.0
9.5
13
6
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
9.4
9
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.7
9.1
31
75
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
11.5
9.0
16
15
WX402
NOMESCO Finland
General anaesthesia
3.5
8.8
44
150
N02AX02
ATC
tramadol; systemic, rectal
2.6
8.7
78
390
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
8.4
8
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
8.4
8
*
Y05
ICPC
Scrotum/testis sympt/compl other
9.4
7.7
15
17
ZX120
NOMESCO Finland
Intravenous
4.8
7.4
24
55
A02BC02
ATC
pantoprazole; systemic
2.3
7.4
107
668
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
7.3
7
*
Y78
ICPC
Malign neopl male genital other
+∞
7.3
7
*
WX320
NOMESCO Finland
Spinalanesthesy
3.2
7.3
40
145
WZC30
NOMESCO Finland
Teaching
3.6
7.2
33
105
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
12.7
7.2
12
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
7.1
23
53
N02AA05
ATC
oxycodone; systemic
3.8
6.8
28
82
M04AA01
ATC
allopurinol; systemic
4.0
6.7
26
72
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
72.0
6.5
7
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
72.0
6.5
7
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
27.6
6.3
8
*
R50.9
ICD-10 Finland
Fever, unspecified
3.0
6.2
36
136
E29.1
ICD-10 Finland
Testicular hypofunction
7.1
6.1
14
21
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
6.1
25
73
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023323) Follitropin [Units/volume] in Serum or Plasma
72
41
25.35
92.75
3.4
1.4
iu/l
18.3
9.5
1.92
55
31
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
80
7
175.73
80.15
12.1
1.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
86
98
13.59
74.33
3.2
1.5
u/l
8.7
4.8
2.75
70
89
(4035726)
72
78
13.10
63.76
1.1
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
83
231
5.11
29.05
1.4
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
34
44
8.92
25.38
1.4
4.0
%
177.3
172.1
0.09
34
44
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
94
325
4.25
24.29
1.6
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
94
334
4.12
23.23
1.7
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
126
584
3.63
20.36
9.9
7.8
mmol/l
1.2
1.2
0.34
102
509
(40768804) Tissue Pathology biopsy report
107
448
3.65
20.24
1.9
1.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
27
36
8.39
19.53
2.6
5.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
27
36
8.39
19.53
1.3
2.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
97
392
3.59
19.20
6.1
2.8
mmol/l
2.4
2.4
0.37
89
357
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
115
537
3.33
17.73
4.7
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
89
362
3.41
17.11
2.8
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
94
398
3.34
16.89
1.4
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
159
932
3.41
16.18
14.2
10.4
e9/l
3.4
4.1
4.90
145
820
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
282
3.42
15.61
2.4
2.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
91
398
3.16
15.21
3.3
2.6
e6/l
17.8
203.6
0.59
70
303
(3030467) Casts [#/volume] in Urine by Automated count
84
360
3.13
14.42
3.0
2.6
e6/l
0.6
0.3
0.37
64
263
(3024561) Albumin [Mass/volume] in Serum or Plasma
114
581
2.95
14.31
11.4
4.9
g/l
36.9
37.6
0.66
107
548
(3023368) Bacteria identified in Blood by Culture
87
382
3.08
14.30
7.0
4.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
97
453
3.01
14.28
3.9
3.0
e6/l
51.8
125.9
0.38
72
314
(42870588) Differential panel, method unspecified - Blood
106
524
2.93
14.01
5.2
6.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
83
361
3.06
13.79
2.9
2.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
99
475
2.94
13.78
3.3
2.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
30
7.22
12.97
3.9
3.2
u/ml
0.3
0.3
0.04
12
15
(46235355) HIV 1 and 2 tests - Meaningful Use set
100
496
2.83
12.90
2.0
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
57
207
3.35
12.74
2.8
2.4
e6/l
0.6
0.7
0.09
33
103
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
58
216
3.27
12.42
2.8
2.4
e6/l
1.0
0.7
0.29
34
110
(3037467) Urinalysis macro (dipstick) panel - Urine
147
910
2.78
11.98
3.9
3.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
76
337
2.90
11.96
7.5
3.5
ph
7.4
7.4
0.66
26
60
(3002030) Lymphocytes/100 leukocytes in Blood
134
806
2.64
11.35
5.9
7.0
%
27.8
28.9
0.51
129
780
(3032080) INR in Blood by Coagulation assay
93
482
2.58
10.56
8.9
7.7
inr
1.1
1.2
0.38
29
156
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
70
317
2.75
10.41
1.6
2.1
mg/l
1.7
1.1
0.82
50
229
(3021589) Normoblasts [#/volume] in Blood
121
725
2.45
9.88
9.8
8.9
e9/l
0.0
0.0
0.62
96
589
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
205
1600
4.16
9.69
20.8
9.2
ml/min/173m2
97.1
95.9
0.30
184
1295
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
28
79
3.91
9.00
5.4
2.9
mmol/l
1.2
1.2
0.24
28
71
(3026782) Osmolality of Urine
58
257
2.69
8.85
2.3
2.2
mosm/kgh2o
605.0
580.9
0.27
51
218
(3002256) Pathology report gross observation
39
140
3.16
8.70
1.2
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
131
845
2.32
8.64
5.8
7.5
e9/l
1.7
1.9
1.69
116
759
(3001604) Monocytes [#/volume] in Blood
127
810
2.30
8.59
5.4
7.4
e9/l
0.6
0.6
0.05
108
717
(3006315) Basophils [#/volume] in Blood
127
812
2.29
8.51
5.4
7.4
e9/l
0.0
0.0
0.27
108
722
(3000850) Epithelial cells [#/volume] in Urine
57
258
2.62
8.30
2.7
2.2
e6/l
3.5
2.4
0.37
50
228
(3013115) Eosinophils [#/volume] in Blood
128
829
2.26
8.22
5.7
8.1
e9/l
0.2
0.2
2.05
111
743
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
48
200
2.78
8.21
2.6
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
24
68
3.83
7.65
2.6
5.4
ug/l
4.9
67.6
0.51
18
57
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
27
5.46
7.06
2.2
4.4
%
59.9
54.0
1.17
14
27
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
27
5.46
7.06
2.1
4.2
e9/l
3.8
3.6
0.10
14
27
(3019225) pH of Specimen
29
102
3.12
6.66
5.3
4.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
206
1727
3.28
6.32
23.0
10.6
mg/l
22.0
23.7
0.34
176
1306
(40758558) Short blood count panel - Blood
70
395
2.12
5.96
11.4
6.9
—
—
—
0
0
(3013512) EKG study
61
335
2.13
5.53
3.3
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
31
127
2.67
5.41
4.0
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
146
2.57
5.40
2.7
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
81
3.05
5.26
1.3
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
215
1892
4.07
5.19
15.2
8.4
u/l
34.2
35.4
0.43
215
1846
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
150
2.41
4.65
2.7
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
39
3.76
4.56
2.1
2.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
6
11.98
4.30
1.0
3.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
6
11.98
4.30
1.0
3.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
6
11.98
4.30
1.0
3.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
23
4.50
4.13
1.0
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
207
1829
2.65
4.05
23.2
9.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
7
10.27
4.04
1.0
3.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
7
10.27
4.04
1.0
3.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
7
10.27
4.04
2.6
1.3
u/l
186.1
185.7
—
7
7
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
7
10.27
4.04
1.0
3.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
7
10.27
4.04
1.0
3.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
43
3.41
3.98
1.6
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
43
3.41
3.98
1.6
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
34
3.67
3.82
1.1
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
34
171
2.16
3.79
3.1
2.1
%
25.3
26.7
0.21
29
153
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
67
2.83
3.76
10.3
16.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
68
2.79
3.66
1.7
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
93
661
1.69
3.56
2.9
2.6
estimate
0.0
0.0
0.00
24
122
(3019832) Treponema pallidum Ab [Presence] in Serum
37
197
2.05
3.56
1.7
2.0
—
—
—
0
0
(3000492) Spirometry study
41
228
1.98
3.50
2.2
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
29
142
2.20
3.45
7.6
7.8
—
—
—
0
0
(4038314)
7
10
7.18
3.39
1.1
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
92
663
1.66
3.29
4.4
3.6
estimate
0.0
0.0
0.00
25
126
(3019230) Fractional oxyhemoglobin in Venous blood
10
28
3.69
3.23
1.6
3.5
%
68.3
68.2
—
10
28
(40761536) Microorganisms panel - Urine sediment
23
107
2.28
3.09
3.1
2.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
17
4.84
2.94
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
22
4.22
2.91
1.0
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
104
2.24
2.85
2.7
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
18
4.57
2.82
1.0
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
18
4.57
2.82
1.0
2.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
18
4.57
2.82
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
18
4.57
2.82
1.1
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
18
4.57
2.82
1.0
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
127
1023
1.55
2.68
3.3
3.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
15
61
2.56
2.68
3.5
2.9
mmol/l
23.0
24.7
1.13
15
56
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
38
2.99
2.62
2.3
2.1
—
—
—
0
0
(4268621)
8
20
4.11
2.59
2.5
2.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
20
95
2.21
2.58
5.4
10.1
%
95.7
93.7
1.52
20
95
(3009261) Glucose [Presence] in Urine by Test strip
89
668
1.55
2.55
3.0
2.6
estimate
0.0
0.0
0.00
21
112
(3011648) Oxygen content in Venous blood
7
16
4.48
2.49
1.6
5.3
%
11.9
12.1
—
7
16
(3008037) Lactate [Moles/volume] in Venous blood
8
21
3.91
2.48
5.1
2.7
mmol/l
1.3
1.5
—
8
21
(3042936) Bacteria identified in Isolate by Culture
34
200
1.82
2.46
2.0
2.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
217
2049
2.66
2.44
34.2
14.8
e9/l
237.8
241.7
0.51
211
2000
(3026008) Bacteria identified in Urine by Culture
30
170
1.88
2.43
2.8
2.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
17
4.21
2.38
5.4
3.1
mmol/l
6.8
7.7
—
7
17
(3000963) Hemoglobin [Mass/volume] in Blood
217
2053
2.60
2.31
34.3
14.9
g/l
141.3
147.4
5.90
217
2026
(3010813) Leukocytes [#/volume] in Blood
217
2052
2.62
2.30
34.1
14.9
e9/l
6.4
6.5
0.18
211
2005
(3024731) MCV [Entitic volume]
217
2052
2.62
2.30
34.0
14.8
fl
89.4
89.4
0.11
217
2028
(3026361) Erythrocytes [#/volume] in Blood
217
2052
2.62
2.30
34.1
14.8
e12/l
4.7
4.9
4.07
210
2001
(3035941) MCH [Entitic mass]
217
2051
2.63
2.30
33.9
14.8
pg
30.2
30.2
0.17
217
2027
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
89
684
1.50
2.22
3.4
3.4
ug/l
1.2
1.6
1.28
77
626
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
31
2.98
2.09
1.1
1.1
—
—
—
0
0
(4034850)
0
57
0.00
2.08
0.0
7.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
23
126
1.92
2.07
8.6
13.0
g/l
119.3
133.2
1.68
23
119
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
12
50
2.48
2.06
2.2
2.4
ug/l
218.4
295.7
0.23
12
50
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
70
523
1.49
1.97
2.8
2.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
33
2.80
1.95
1.4
4.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
22
3.25
1.89
1.4
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
40
2.57
1.86
1.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
73
2.13
1.85
3.5
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
42
284
1.59
1.85
2.3
3.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
157
1738
0.68
1.83
4.2
3.8
mmol/l
2.9
2.9
0.26
149
1639
(3041096) Erythrocytes [Presence] in Urine by Automated
54
388
1.52
1.82
3.1
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
41
2.51
1.78
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
111
1.88
1.75
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
24
2.98
1.73
2.1
3.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
24
2.98
1.73
2.1
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
24
2.98
1.73
1.1
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
10
42
2.45
1.70
11.3
16.3
%
0.9
0.9
—
10
36
(3023520) Reticulocytes [#/volume] in Blood
15
76
2.04
1.68
2.4
4.9
e9/l
41.5
73.2
—
9
53
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
49
2.31
1.66
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
25
2.86
1.66
2.1
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
43
2.39
1.62
2.8
2.9
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
50
2.26
1.59
1.2
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
10
44
2.33
1.55
11.3
15.7
%
1.4
1.5
—
10
37
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
157
1723
0.71
1.55
4.1
3.6
mmol/l
4.6
4.7
0.12
152
1632
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
43
0.00
1.54
0.0
1.1
—
8.8
—
0
32
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
15
3.38
1.53
2.4
3.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
16
87
1.90
1.50
6.0
4.5
mmol/l
24.3
23.7
0.33
16
80
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
37
2.49
1.49
1.9
4.0
—
4465.3
—
0
6
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
157
1715
0.72
1.41
4.0
3.5
mmol/l
1.2
1.3
4.30
151
1625
(4306422)
7
29
2.46
1.40
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
17
2.98
1.36
1.0
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
137
1.67
1.35
3.6
4.6
%
4.0
0.7
1.77
12
41
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
42
2.19
1.35
1.2
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
91
1.82
1.33
3.4
2.8
mmol/l
-0.7
1.3
1.19
11
60
(42529406) Shigella sp [Presence] in Stool by Culture
11
55
2.05
1.29
1.6
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
28
190
1.54
1.24
1.5
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
123
1079
1.31
1.19
3.9
3.5
mm/h
10.8
8.3
0.96
118
1012
(21494755) Public health laboratory ask at order entry panel
25
361
0.65
1.19
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
152
1654
0.75
1.18
3.7
3.3
mmol/l
1.5
1.4
1.34
145
1569
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
33
0.00
1.17
0.0
1.0
—
1.4
—
0
8
(3002179) Metamyelocytes/100 leukocytes in Blood
20
127
1.63
1.16
2.4
4.4
%
2.7
0.4
—
10
31
(3007566) Smooth muscle Ab [Titer] in Serum
12
65
1.89
1.16
1.2
1.2
—
58.0
—
0
10
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
35
254
1.45
1.14
2.3
3.1
ng/l
609.2
1458.5
0.67
28
192
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
31
2.30
1.11
2.1
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
7
31
2.30
1.11
1.6
1.4
ug/g
316.9
326.4
—
7
19
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
273
1.43
1.10
4.0
3.3
ng/l
657.1
1088.9
0.31
28
189
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
62
501
1.33
1.07
3.7
3.0
ng/l
41.5
62.8
0.29
43
276
(1761868) Lipid panel - Serum or Plasma
63
763
0.76
1.07
2.8
2.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
34
2.09
1.04
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
34
2.09
1.04
1.7
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
9
48
1.91
1.01
1.2
1.3
—
83.7
—
0
9
(3029937) Albumin [Presence] in Urine by Test strip
43
331
1.37
1.01
3.1
2.8
estimate
0.1
0.0
0.42
24
119
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
525
1.31
0.99
3.2
3.4
%
24.5
21.2
0.35
18
170
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
54
1.89
0.98
1.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
55
1.86
0.93
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
55
1.86
0.93
1.3
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
55
446
1.31
0.92
2.2
1.6
pmol/l
92.4
96.9
0.28
36
227
(1616796) Gas panel - Central venous blood
6
29
2.10
0.90
2.8
2.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
42
1.94
0.89
10.8
2.9
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
64
1.76
0.88
8.5
2.8
%
60.8
59.7
0.05
11
64
(3012501) Base excess in Blood by calculation
6
30
2.03
0.87
5.8
2.3
mmol/l
3.1
2.6
—
6
13
(3013290) Carbon dioxide [Partial pressure] in Blood
6
30
2.03
0.87
5.8
2.3
kpa
5.3
5.1
—
6
30
(3027315) Oxygen [Partial pressure] in Blood
6
30
2.03
0.87
5.8
2.3
kpa
9.0
8.4
—
6
30
(3034770) Mitochondria Ab [Titer] in Serum
11
65
1.73
0.84
1.3
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
32
1.90
0.82
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
28
209
1.39
0.80
1.2
1.3
titre
262.9
287.4
—
7
27
(3021440) Promyelocytes/100 leukocytes in Blood
19
132
1.48
0.79
3.8
4.7
%
0.9
0.2
1.51
11
38
(40760892) CBC W Ordered Manual Differential panel - Blood
48
393
1.28
0.75
4.0
5.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
24
2.11
0.75
1.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
24
2.11
0.75
1.2
1.8
—
—
—
0
0
(44790049)
5
24
2.11
0.75
2.4
1.8
—
—
—
0
0
(44790047)
5
24
2.11
0.75
2.4
1.8
—
—
—
0
0
(44806118)
5
24
2.11
0.75
2.4
1.8
—
—
—
0
0
(44790048)
5
24
2.11
0.75
2.4
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
60
1.70
0.73
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
101
1.52
0.72
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
144
1541
0.82
0.71
3.6
3.4
mmol/l
6.0
5.9
0.21
136
1440
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
41
1.73
0.70
2.9
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
187
1784
1.29
0.69
26.1
10.6
%
40.5
43.1
3.02
162
1520
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.2
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
130
0.60
0.66
1.0
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
46
382
1.26
0.65
1.7
2.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
29
1.74
0.64
1.0
1.2
—
—
—
0
0
(4010399)
14
96
1.49
0.63
1.0
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
41
339
1.26
0.61
3.8
3.9
mg/l
31.3
257.5
0.68
31
247
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
20
0.00
0.60
0.0
2.6
—
580.7
—
0
15
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
72
1.55
0.60
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
23
176
1.34
0.59
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
262
0.74
0.59
2.9
2.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
262
0.74
0.59
2.3
2.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
124
1.40
0.57
4.1
4.8
%
0.0
0.0
—
10
33
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
73
1.53
0.57
3.6
2.9
ng/l
57.3
147.3
1.07
11
62
(3001019) Free T4 and TSH panel - Serum or Plasma
5
89
0.55
0.57
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
259
0.75
0.55
2.3
2.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
60
1.52
0.55
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
9
60
1.52
0.55
2.9
5.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
117
1082
1.17
0.53
3.0
2.8
pmol/l
15.1
14.9
0.46
104
1001
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
202
0.72
0.53
2.7
3.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
257
0.76
0.52
2.3
2.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
137
1451
0.86
0.50
5.0
4.4
mmol/mol
39.4
38.8
0.23
131
1392
(3016879) Cocaine [Presence] in Urine
19
244
0.76
0.50
2.4
2.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
46
397
1.20
0.47
2.8
2.3
ug/l
0.6
0.7
0.51
28
201
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
50
1.41
0.45
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
91
0.65
0.43
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
31
1.63
0.43
1.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
70
1.45
0.42
1.5
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
33
1.53
0.41
1.4
1.5
g/l
0.4
0.9
—
5
23
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
2.5
—
0
15
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
71
1.43
0.40
1.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
44
388
1.17
0.36
2.0
1.7
mmol/l
1.7
1.6
0.17
38
342
(3022145) Colonoscopy Study observation
20
163
1.25
0.35
1.8
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
41
361
1.17
0.34
4.3
4.7
mg/mmol
8.8
12.8
0.26
32
268
(3011288) Drugs identified in Urine by Screen method
14
176
0.78
0.33
3.6
4.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
110
1.29
0.32
1.3
1.3
—
—
—
0
0
(1002224) Polysomnography panel
10
130
0.76
0.30
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
55
1.28
0.30
1.7
2.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
57
1.24
0.29
1.1
2.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
351
1.13
0.25
1.7
2.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
162
1665
0.90
0.25
30.9
12.8
g/l
337.0
337.4
0.22
162
1660
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
264
0.86
0.24
1.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
38
1.32
0.23
1.0
2.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
10
79
1.28
0.22
1.2
2.0
—
9.2
—
0
7
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
37
407
0.89
0.22
1.2
1.2
u/ml
0.5
1.0
—
9
121
(3045414) Leukocytes [Presence] in Urine
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
101
0.78
0.21
2.1
3.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
42
1.19
0.21
3.6
1.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
234.3
—
0
11
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
3.2
—
96.5
—
0
11
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
10
0.00
0.21
0.0
2.0
—
33.2
—
0
10
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(4146454)
0
12
0.00
0.21
0.0
3.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.4
—
0
5
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
4.5
—
770.5
—
0
14
(3020961) Endomysium IgA Ab [Titer] in Serum
11
91
1.22
0.18
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
61
1.15
0.17
2.1
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
148
1517
0.93
0.17
3.2
3.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
110
1.19
0.17
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
39
362
1.09
0.16
1.4
1.4
g/l
2.5
2.4
0.24
28
243
(3008152) Bicarbonate [Moles/volume] in Arterial blood
9
81
1.12
0.15
12.8
14.7
mmol/l
23.6
24.0
—
9
73
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
95
0.84
0.14
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
108
0.83
0.13
3.1
4.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
141
1380
1.06
0.13
3.6
3.4
mu/l
1.7
2.7
0.58
130
1289
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
136
0.88
0.11
9.8
7.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.4
3.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
23
213
1.09
0.10
1.4
1.7
pmol/l
406.1
419.7
0.14
18
196
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
43
450
0.95
0.09
1.6
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
51
490
1.05
0.08
3.5
3.9
mmol/l
9.9
9.5
0.19
43
434
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
58
1.04
0.08
1.2
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
347
0.94
0.08
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
122
0.90
0.07
3.1
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
19
178
1.07
0.06
1.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
90
1.12
0.05
11.2
9.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
102
1.08
0.03
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
103
1.07
0.02
2.6
2.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
138
1.02
0.00
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
182
0.99
0.00
1.2
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
69
1.01
0.00
1.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
9
0.00
0.00
0.0
3.0
—
27.7
—
0
9
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
35.7
—
0
6
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
9
0.00
0.00
0.0
8.8
—
—
—
0
0
(44813793)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
42.8
—
0
5
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
50
1.00
0.00
1.0
1.1
—
1.0
—
0
8
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
7.0
—
0
5
(3005322) IgE [Units/volume] in Serum or Plasma
9
95
0.95
0.00
1.1
1.2
u/ml
197.0
209.4
—
9
88
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
137.8
—
0
6
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
16.1
—
0
7
(4133840)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
109.7
—
0
7
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
11.0
—
0
8
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
9
0.00
0.00
0.0
5.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
0
9
0.00
0.00
0.0
4.6
—
8.1
—
0
9
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
9
0.00
0.00
0.0
1.3
—
330.7
—
0
9
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TESTIS_NONSEMINOMA – Non-seminoma of testis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).